OMCL:NSD-Omnicell Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 47.81

Change

-1.08 (-2.21)%

Market Cap

USD 2.24B

Volume

0.33M

Analyst Target

USD 81.29
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-13 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
GEHC GE HealthCare Technologies Inc..

-0.74 (-0.87%)

USD 39.84B
TEM Tempus AI, Inc. Class A Common..

+0.04 (+0.06%)

USD 7.92B
HQY HealthEquity Inc

-5.40 (-5.39%)

USD 7.54B
RCM R1 RCM Inc

+0.01 (+0.07%)

USD 6.02B
WAY Waystar Holding Corp. Common S..

-0.15 (-0.47%)

USD 4.47B
BTSG BrightSpring Health Services, ..

+0.12 (+0.61%)

USD 2.71B
GDRX Goodrx Holdings Inc

-0.04 (-0.85%)

USD 2.43B
WGS GeneDx Holdings Corp.

+1.56 (+2.03%)

USD 2.29B
PRVA Privia Health Group Inc

-0.74 (-3.28%)

USD 2.27B
PINC Premier Inc

+0.16 (+0.70%)

USD 1.96B

ETFs Containing OMCL

XHE SPDR® S&P Health Care Eq.. 2.09 % 0.35 %

-1.55 (-0.43%)

USD 0.22B
NIXT Research Affiliates Delet.. 1.26 % 0.00 %

-0.12 (-0.43%)

USD 0.03B
ROBO Robo Global® Robotics an.. 0.00 % 0.00 %

-0.35 (-0.43%)

USD 1.08B
ROBO Robo Global® Robotics an.. 0.00 % 0.95 %

-0.35 (-0.43%)

USD 1.08B
SBB ProShares Short SmallCap6.. 0.00 % 0.95 %

+0.10 (+-0.43%)

N/A
SDD ProShares UltraShort Smal.. 0.00 % 0.95 %

+0.21 (+-0.43%)

N/A
ISMD Inspire Small/Mid Cap Imp.. 0.00 % 0.62 %

-0.27 (-0.43%)

USD 0.19B
DMRS 0.00 % 0.45 %

N/A

N/A
IJR:AU iShares Core S&P SmallCap.. 0.00 % 0.00 %

-2.87 (-0.43%)

USD 0.54B

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 27.05% 77% C+ 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 27.05% 75% C 78% C+
Trailing 12 Months  
Capital Gain 43.06% 87% B+ 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 43.06% 87% B+ 79% B-
Trailing 5 Years  
Capital Gain -36.24% 62% D 31% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -36.24% 62% D 29% F
Average Annual (5 Year Horizon)  
Capital Gain -1.31% 57% F 35% F
Dividend Return -1.31% 57% F 32% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 61.53% 29% F 32% F
Risk Adjusted Return -2.14% 60% D- 33% F
Market Capitalization 2.24B 81% B- 81% B-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector